CA2019048C - Methode de dosage immunologique - Google Patents

Methode de dosage immunologique Download PDF

Info

Publication number: CA2019048C
Authority: CA; Canada
Prior art keywords: cloth; antibody; antigen; antibodies; immunoassay
Prior art date: 1990-06-14
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

CA 2019048

Other languages

English (en)

Other versions

CA2019048A1 (fr

Inventor

Hiroshi Yamazaki

Burton Walter Blais

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

567782 Bc Ltd

Original Assignee

567782 Bc Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-06-14

Filing date

1990-06-14

Publication date

2003-02-25

1990-06-14 Application filed by 567782 Bc Ltd filed Critical 567782 Bc Ltd

1990-06-14 Priority to CA 2019048 priority Critical patent/CA2019048C/fr

1991-12-14 Publication of CA2019048A1 publication Critical patent/CA2019048A1/fr

2003-02-25 Application granted granted Critical

2003-02-25 Publication of CA2019048C publication Critical patent/CA2019048C/fr

2010-06-14 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

239000004744 fabric Substances 0.000 title claims abstract description 569
238000003018 immunoassay Methods 0.000 title claims abstract description 301
102000004190 Enzymes Human genes 0.000 title claims description 206
108090000790 Enzymes Proteins 0.000 title claims description 206
239000000427 antigen Substances 0.000 claims abstract description 370
108091007433 antigens Proteins 0.000 claims abstract description 366
102000036639 antigens Human genes 0.000 claims abstract description 366
238000000034 method Methods 0.000 claims abstract description 126
230000002209 hydrophobic effect Effects 0.000 claims abstract description 102
238000012360 testing method Methods 0.000 claims abstract description 82
229920001059 synthetic polymer Polymers 0.000 claims abstract description 46
230000035699 permeability Effects 0.000 claims abstract description 26
239000002158 endotoxin Substances 0.000 claims description 121
241000607142 Salmonella Species 0.000 claims description 115
229920006008 lipopolysaccharide Polymers 0.000 claims description 111
229920000728 polyester Polymers 0.000 claims description 81
238000003556 assay Methods 0.000 claims description 80
238000001514 detection method Methods 0.000 claims description 77
210000002966 serum Anatomy 0.000 claims description 72
-1 polypropylene Polymers 0.000 claims description 66
239000000243 solution Substances 0.000 claims description 63
238000011534 incubation Methods 0.000 claims description 50
239000004743 Polypropylene Substances 0.000 claims description 48
210000002969 egg yolk Anatomy 0.000 claims description 47
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical group OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 claims description 44
229940071106 ethylenediaminetetraacetate Drugs 0.000 claims description 44
229920001155 polypropylene Polymers 0.000 claims description 44
239000000463 material Substances 0.000 claims description 38
239000007787 solid Substances 0.000 claims description 38
239000000872 buffer Substances 0.000 claims description 36
238000005406 washing Methods 0.000 claims description 36
241000589567 Brucella abortus Species 0.000 claims description 33
229940127121 immunoconjugate Drugs 0.000 claims description 33
235000013345 egg yolk Nutrition 0.000 claims description 32
238000002360 preparation method Methods 0.000 claims description 31
238000010438 heat treatment Methods 0.000 claims description 27
102000002322 Egg Proteins Human genes 0.000 claims description 24
108010000912 Egg Proteins Proteins 0.000 claims description 24
239000011248 coating agent Substances 0.000 claims description 23
238000000576 coating method Methods 0.000 claims description 23
241000283973 Oryctolagus cuniculus Species 0.000 claims description 22
108091003079 Bovine Serum Albumin Proteins 0.000 claims description 21
230000027455 binding Effects 0.000 claims description 21
229940098773 bovine serum albumin Drugs 0.000 claims description 21
102000013415 peroxidase activity proteins Human genes 0.000 claims description 20
108040007629 peroxidase activity proteins Proteins 0.000 claims description 20
239000004677 Nylon Substances 0.000 claims description 17
230000008878 coupling Effects 0.000 claims description 17
238000010168 coupling process Methods 0.000 claims description 17
238000005859 coupling reaction Methods 0.000 claims description 17
239000012528 membrane Substances 0.000 claims description 17
229920001778 nylon Polymers 0.000 claims description 17
238000000605 extraction Methods 0.000 claims description 16
239000003153 chemical reaction reagent Substances 0.000 claims description 15
239000000203 mixture Substances 0.000 claims description 15
239000004698 Polyethylene Substances 0.000 claims description 12
230000015572 biosynthetic process Effects 0.000 claims description 12
239000003593 chromogenic compound Substances 0.000 claims description 12
229920000573 polyethylene Polymers 0.000 claims description 12
241000894006 Bacteria Species 0.000 claims description 11
238000005119 centrifugation Methods 0.000 claims description 11
241000283707 Capra Species 0.000 claims description 10
210000001124 body fluid Anatomy 0.000 claims description 8
239000010839 body fluid Substances 0.000 claims description 8
210000000991 chicken egg Anatomy 0.000 claims description 8
238000001914 filtration Methods 0.000 claims description 8
239000007853 buffer solution Substances 0.000 claims description 7
229940027941 immunoglobulin g Drugs 0.000 claims description 6
239000002738 chelating agent Substances 0.000 claims description 5
238000000746 purification Methods 0.000 claims description 4
239000013522 chelant Substances 0.000 claims description 2
238000000926 separation method Methods 0.000 claims description 2
239000003352 sequestering agent Substances 0.000 claims 1
239000007788 liquid Substances 0.000 abstract description 27
229940088598 enzyme Drugs 0.000 description 202
239000000562 conjugate Substances 0.000 description 111
210000004027 cell Anatomy 0.000 description 99
239000000523 sample Substances 0.000 description 93
230000036046 immunoreaction Effects 0.000 description 55
239000007790 solid phase Substances 0.000 description 49
UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 44
238000010790 dilution Methods 0.000 description 35
239000012895 dilution Substances 0.000 description 35
229940072417 peroxidase Drugs 0.000 description 33
241000283690 Bos taurus Species 0.000 description 32
241000293869 Salmonella enterica subsp. enterica serovar Typhimurium Species 0.000 description 26
238000006243 chemical reaction Methods 0.000 description 24
230000000694 effects Effects 0.000 description 24
102000004169 proteins and genes Human genes 0.000 description 24
108090000623 proteins and genes Proteins 0.000 description 24
235000018102 proteins Nutrition 0.000 description 23
230000008901 benefit Effects 0.000 description 18
239000003463 adsorbent Substances 0.000 description 17
238000007413 biotinylation Methods 0.000 description 17
230000006287 biotinylation Effects 0.000 description 17
239000006228 supernatant Substances 0.000 description 17
235000013330 chicken meat Nutrition 0.000 description 16
108010001336 Horseradish Peroxidase Proteins 0.000 description 15
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 15
230000035945 sensitivity Effects 0.000 description 15
239000000126 substance Substances 0.000 description 15
239000000758 substrate Substances 0.000 description 15
238000002835 absorbance Methods 0.000 description 14
235000010633 broth Nutrition 0.000 description 14
238000002474 experimental method Methods 0.000 description 14
241001465754 Metazoa Species 0.000 description 13
239000002250 absorbent Substances 0.000 description 13
238000001261 affinity purification Methods 0.000 description 13
235000013601 eggs Nutrition 0.000 description 13
238000011084 recovery Methods 0.000 description 13
230000002745 absorbent Effects 0.000 description 12
239000000725 suspension Substances 0.000 description 12
102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 11
108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 11
238000001179 sorption measurement Methods 0.000 description 11
210000001519 tissue Anatomy 0.000 description 11
229910001868 water Inorganic materials 0.000 description 11
UVGHPGOONBRLCX-NJSLBKSFSA-N (2,5-dioxopyrrolidin-1-yl) 6-[5-[(3as,4s,6ar)-2-oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-4-yl]pentanoylamino]hexanoate Chemical compound C([C@H]1[C@H]2NC(=O)N[C@H]2CS1)CCCC(=O)NCCCCCC(=O)ON1C(=O)CCC1=O UVGHPGOONBRLCX-NJSLBKSFSA-N 0.000 description 10
241000589562 Brucella Species 0.000 description 10
239000004793 Polystyrene Substances 0.000 description 10
CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 10
OHDRQQURAXLVGJ-HLVWOLMTSA-N azane;(2e)-3-ethyl-2-[(e)-(3-ethyl-6-sulfo-1,3-benzothiazol-2-ylidene)hydrazinylidene]-1,3-benzothiazole-6-sulfonic acid Chemical compound [NH4+].[NH4+].S/1C2=CC(S([O-])(=O)=O)=CC=C2N(CC)C\1=N/N=C1/SC2=CC(S([O-])(=O)=O)=CC=C2N1CC OHDRQQURAXLVGJ-HLVWOLMTSA-N 0.000 description 10
229920003023 plastic Polymers 0.000 description 10
239000004033 plastic Substances 0.000 description 10
239000011780 sodium chloride Substances 0.000 description 10
238000007654 immersion Methods 0.000 description 9
239000013642 negative control Substances 0.000 description 9
229920002223 polystyrene Polymers 0.000 description 9
239000000020 Nitrocellulose Substances 0.000 description 8
FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 8
201000010099 disease Diseases 0.000 description 8
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 8
230000003993 interaction Effects 0.000 description 8
229920001220 nitrocellulos Polymers 0.000 description 8
QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 7
241000588724 Escherichia coli Species 0.000 description 7
206010034203 Pectus Carinatum Diseases 0.000 description 7
230000001900 immune effect Effects 0.000 description 7
239000003446 ligand Substances 0.000 description 7
239000011159 matrix material Substances 0.000 description 7
235000015097 nutrients Nutrition 0.000 description 7
230000036961 partial effect Effects 0.000 description 7
244000052769 pathogen Species 0.000 description 7
239000000047 product Substances 0.000 description 7
230000004044 response Effects 0.000 description 7
238000011282 treatment Methods 0.000 description 7
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
208000035473 Communicable disease Diseases 0.000 description 6
229920000742 Cotton Polymers 0.000 description 6
241000282412 Homo Species 0.000 description 6
239000004772 Sontara Substances 0.000 description 6
229940081735 acetylcellulose Drugs 0.000 description 6
210000004369 blood Anatomy 0.000 description 6
239000008280 blood Substances 0.000 description 6
238000004925 denaturation Methods 0.000 description 6
230000036425 denaturation Effects 0.000 description 6
238000003745 diagnosis Methods 0.000 description 6
238000010828 elution Methods 0.000 description 6
210000003608 fece Anatomy 0.000 description 6
235000013305 food Nutrition 0.000 description 6
238000005755 formation reaction Methods 0.000 description 6
235000013372 meat Nutrition 0.000 description 6
229940079938 nitrocellulose Drugs 0.000 description 6
229920000136 polysorbate Polymers 0.000 description 6
239000011148 porous material Substances 0.000 description 6
238000000159 protein binding assay Methods 0.000 description 6
230000035484 reaction time Effects 0.000 description 6
230000009870 specific binding Effects 0.000 description 6
229960005486 vaccine Drugs 0.000 description 6
206010006500 Brucellosis Diseases 0.000 description 5
241000287828 Gallus gallus Species 0.000 description 5
208000032843 Hemorrhage Diseases 0.000 description 5
229910019142 PO4 Inorganic materials 0.000 description 5
229920001213 Polysorbate 20 Polymers 0.000 description 5
206010051511 Viral diarrhoea Diseases 0.000 description 5
208000034158 bleeding Diseases 0.000 description 5
231100000319 bleeding Toxicity 0.000 description 5
230000000740 bleeding effect Effects 0.000 description 5
239000012141 concentrate Substances 0.000 description 5
238000009792 diffusion process Methods 0.000 description 5
238000010494 dissociation reaction Methods 0.000 description 5
230000005593 dissociations Effects 0.000 description 5
239000000835 fiber Substances 0.000 description 5
239000012530 fluid Substances 0.000 description 5
238000005259 measurement Methods 0.000 description 5
239000002609 medium Substances 0.000 description 5
230000001717 pathogenic effect Effects 0.000 description 5
239000008188 pellet Substances 0.000 description 5
239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 5
235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 5
230000002829 reductive effect Effects 0.000 description 5
230000000717 retained effect Effects 0.000 description 5
229910000029 sodium carbonate Inorganic materials 0.000 description 5
235000017550 sodium carbonate Nutrition 0.000 description 5
IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 4
241000700605 Viruses Species 0.000 description 4
230000000890 antigenic effect Effects 0.000 description 4
229920002301 cellulose acetate Polymers 0.000 description 4
230000003247 decreasing effect Effects 0.000 description 4
150000002148 esters Chemical class 0.000 description 4
230000003053 immunization Effects 0.000 description 4
238000002649 immunization Methods 0.000 description 4
230000006872 improvement Effects 0.000 description 4
238000002347 injection Methods 0.000 description 4
239000007924 injection Substances 0.000 description 4
KHIWWQKSHDUIBK-UHFFFAOYSA-N periodic acid Chemical compound OI(=O)(=O)=O KHIWWQKSHDUIBK-UHFFFAOYSA-N 0.000 description 4
235000020030 perry Nutrition 0.000 description 4
NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 4
239000010452 phosphate Substances 0.000 description 4
238000012216 screening Methods 0.000 description 4
229940082569 selenite Drugs 0.000 description 4
MCAHWIHFGHIESP-UHFFFAOYSA-L selenite(2-) Chemical compound [O-][Se]([O-])=O MCAHWIHFGHIESP-UHFFFAOYSA-L 0.000 description 4
239000001509 sodium citrate Substances 0.000 description 4
NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 4
HPQYKCJIWQFJMS-UHFFFAOYSA-L tetrathionate(2-) Chemical compound [O-]S(=O)(=O)SSS([O-])(=O)=O HPQYKCJIWQFJMS-UHFFFAOYSA-L 0.000 description 4
XZKIHKMTEMTJQX-UHFFFAOYSA-N 4-Nitrophenyl Phosphate Chemical compound OP(O)(=O)OC1=CC=C([N+]([O-])=O)C=C1 XZKIHKMTEMTJQX-UHFFFAOYSA-N 0.000 description 3
102000002260 Alkaline Phosphatase Human genes 0.000 description 3
108020004774 Alkaline Phosphatase Proteins 0.000 description 3
LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 3
LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 description 3
ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 3
241001222774 Salmonella enterica subsp. enterica serovar Minnesota Species 0.000 description 3
239000011324 bead Substances 0.000 description 3
239000006285 cell suspension Substances 0.000 description 3
229920002678 cellulose Polymers 0.000 description 3
239000001913 cellulose Substances 0.000 description 3
235000010980 cellulose Nutrition 0.000 description 3
239000003795 chemical substances by application Substances 0.000 description 3
238000011109 contamination Methods 0.000 description 3
229960003067 cystine Drugs 0.000 description 3
238000002405 diagnostic procedure Methods 0.000 description 3
238000000502 dialysis Methods 0.000 description 3
239000011521 glass Substances 0.000 description 3
239000001963 growth medium Substances 0.000 description 3
238000011065 in-situ storage Methods 0.000 description 3
230000002458 infectious effect Effects 0.000 description 3
210000001165 lymph node Anatomy 0.000 description 3
235000013336 milk Nutrition 0.000 description 3
210000004080 milk Anatomy 0.000 description 3
239000008267 milk Substances 0.000 description 3
230000003647 oxidation Effects 0.000 description 3
238000007254 oxidation reaction Methods 0.000 description 3
229940070376 protein Drugs 0.000 description 3
238000012207 quantitative assay Methods 0.000 description 3
239000000376 reactant Substances 0.000 description 3
230000000384 rearing effect Effects 0.000 description 3
210000000952 spleen Anatomy 0.000 description 3
239000003381 stabilizer Substances 0.000 description 3
238000003756 stirring Methods 0.000 description 3
239000003053 toxin Substances 0.000 description 3
231100000765 toxin Toxicity 0.000 description 3
108700012359 toxins Proteins 0.000 description 3
230000000007 visual effect Effects 0.000 description 3
239000011534 wash buffer Substances 0.000 description 3
ZAMLGGRVTAXBHI-UHFFFAOYSA-N 3-(4-bromophenyl)-3-[(2-methylpropan-2-yl)oxycarbonylamino]propanoic acid Chemical compound CC(C)(C)OC(=O)NC(CC(O)=O)C1=CC=C(Br)C=C1 ZAMLGGRVTAXBHI-UHFFFAOYSA-N 0.000 description 2
QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
108010032595 Antibody Binding Sites Proteins 0.000 description 2
108010017384 Blood Proteins Proteins 0.000 description 2
102000004506 Blood Proteins Human genes 0.000 description 2
241000589876 Campylobacter Species 0.000 description 2
BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 2
ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 2
201000009906 Meningitis Diseases 0.000 description 2
108091006629 SLC13A2 Proteins 0.000 description 2
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
230000009471 action Effects 0.000 description 2
150000001412 amines Chemical class 0.000 description 2
150000001413 amino acids Chemical class 0.000 description 2
230000009830 antibody antigen interaction Effects 0.000 description 2
238000013459 approach Methods 0.000 description 2
210000000601 blood cell Anatomy 0.000 description 2
229940056450 brucella abortus Drugs 0.000 description 2
239000000969 carrier Substances 0.000 description 2
150000001768 cations Chemical class 0.000 description 2
230000008859 change Effects 0.000 description 2
238000012875 competitive assay Methods 0.000 description 2
230000002860 competitive effect Effects 0.000 description 2
238000002967 competitive immunoassay Methods 0.000 description 2
239000002131 composite material Substances 0.000 description 2
150000001875 compounds Chemical class 0.000 description 2
238000012790 confirmation Methods 0.000 description 2
239000000470 constituent Substances 0.000 description 2
238000007796 conventional method Methods 0.000 description 2
230000037029 cross reaction Effects 0.000 description 2
230000007423 decrease Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
230000000369 enteropathogenic effect Effects 0.000 description 2
238000006911 enzymatic reaction Methods 0.000 description 2
239000000284 extract Substances 0.000 description 2
150000004676 glycans Chemical class 0.000 description 2
244000000058 gram-negative pathogen Species 0.000 description 2
230000005484 gravity Effects 0.000 description 2
229940088597 hormone Drugs 0.000 description 2
239000005556 hormone Substances 0.000 description 2
210000004408 hybridoma Anatomy 0.000 description 2
230000016784 immunoglobulin production Effects 0.000 description 2
208000015181 infectious disease Diseases 0.000 description 2
208000014674 injury Diseases 0.000 description 2
NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
229920002521 macromolecule Polymers 0.000 description 2
230000014759 maintenance of location Effects 0.000 description 2
238000004519 manufacturing process Methods 0.000 description 2
230000000813 microbial effect Effects 0.000 description 2
238000012544 monitoring process Methods 0.000 description 2
229920000642 polymer Polymers 0.000 description 2
229920000193 polymethacrylate Polymers 0.000 description 2
229920001282 polysaccharide Polymers 0.000 description 2
239000005017 polysaccharide Substances 0.000 description 2
239000004800 polyvinyl chloride Substances 0.000 description 2
229920000915 polyvinyl chloride Polymers 0.000 description 2
230000008569 process Effects 0.000 description 2
238000012545 processing Methods 0.000 description 2
230000002035 prolonged effect Effects 0.000 description 2
238000011160 research Methods 0.000 description 2
210000003296 saliva Anatomy 0.000 description 2
150000003839 salts Chemical class 0.000 description 2
229920006395 saturated elastomer Polymers 0.000 description 2
238000011896 sensitive detection Methods 0.000 description 2
238000013207 serial dilution Methods 0.000 description 2
230000000405 serological effect Effects 0.000 description 2
229910000033 sodium borohydride Inorganic materials 0.000 description 2
239000012279 sodium borohydride Substances 0.000 description 2
239000011550 stock solution Substances 0.000 description 2
238000003860 storage Methods 0.000 description 2
239000004753 textile Substances 0.000 description 2
230000008733 trauma Effects 0.000 description 2
LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
230000003612 virological effect Effects 0.000 description 2
XUHRVZXFBWDCFB-QRTDKPMLSA-N (3R)-4-[[(3S,6S,9S,12R,15S,18R,21R,24R,27R,28R)-12-(3-amino-3-oxopropyl)-6-[(2S)-butan-2-yl]-3-(2-carboxyethyl)-18-(hydroxymethyl)-28-methyl-9,15,21,24-tetrakis(2-methylpropyl)-2,5,8,11,14,17,20,23,26-nonaoxo-1-oxa-4,7,10,13,16,19,22,25-octazacyclooctacos-27-yl]amino]-3-[[(2R)-2-[[(3S)-3-hydroxydecanoyl]amino]-4-methylpentanoyl]amino]-4-oxobutanoic acid Chemical compound CCCCCCC[C@H](O)CC(=O)N[C@H](CC(C)C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H]1[C@@H](C)OC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](CO)NC(=O)[C@@H](CC(C)C)NC(=O)[C@@H](CC(C)C)NC1=O)[C@@H](C)CC XUHRVZXFBWDCFB-QRTDKPMLSA-N 0.000 description 1
UAIUNKRWKOVEES-UHFFFAOYSA-N 3,3',5,5'-tetramethylbenzidine Chemical compound CC1=C(N)C(C)=CC(C=2C=C(C)C(N)=C(C)C=2)=C1 UAIUNKRWKOVEES-UHFFFAOYSA-N 0.000 description 1
208000035939 Alveolitis allergic Diseases 0.000 description 1
208000004881 Amebiasis Diseases 0.000 description 1
206010001980 Amoebiasis Diseases 0.000 description 1
208000031295 Animal disease Diseases 0.000 description 1
101710099705 Anti-lipopolysaccharide factor Proteins 0.000 description 1
BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
208000007198 Bovine Brucellosis Diseases 0.000 description 1
201000005709 Brucella abortus brucellosis Diseases 0.000 description 1
241000222120 Candida <Saccharomycetales> Species 0.000 description 1
241000222122 Candida albicans Species 0.000 description 1
206010007134 Candida infections Diseases 0.000 description 1
239000004215 Carbon black (E152) Substances 0.000 description 1
241000221204 Cryptococcus neoformans Species 0.000 description 1
201000003808 Cystic echinococcosis Diseases 0.000 description 1
FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
238000009007 Diagnostic Kit Methods 0.000 description 1
206010014096 Echinococciasis Diseases 0.000 description 1
208000009366 Echinococcosis Diseases 0.000 description 1
241000244170 Echinococcus granulosus Species 0.000 description 1
241000196324 Embryophyta Species 0.000 description 1
241000224432 Entamoeba histolytica Species 0.000 description 1
208000004232 Enteritis Diseases 0.000 description 1
241000305071 Enterobacterales Species 0.000 description 1
208000027445 Farmer Lung Diseases 0.000 description 1
241000242711 Fasciola hepatica Species 0.000 description 1
201000006353 Filariasis Diseases 0.000 description 1
102000002464 Galactosidases Human genes 0.000 description 1
108010093031 Galactosidases Proteins 0.000 description 1
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
206010018612 Gonorrhoea Diseases 0.000 description 1
208000009889 Herpes Simplex Diseases 0.000 description 1
101000591286 Homo sapiens Myocardin-related transcription factor A Proteins 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 1
102000004877 Insulin Human genes 0.000 description 1
108090001061 Insulin Proteins 0.000 description 1
206010022528 Interactions Diseases 0.000 description 1
241000222727 Leishmania donovani Species 0.000 description 1
208000004554 Leishmaniasis Diseases 0.000 description 1
241000187708 Micromonospora Species 0.000 description 1
201000008235 Mycoplasma pneumoniae pneumonia Diseases 0.000 description 1
102100034099 Myocardin-related transcription factor A Human genes 0.000 description 1
HRNLUBSXIHFDHP-UHFFFAOYSA-N N-(2-aminophenyl)-4-[[[4-(3-pyridinyl)-2-pyrimidinyl]amino]methyl]benzamide Chemical compound NC1=CC=CC=C1NC(=O)C(C=C1)=CC=C1CNC1=NC=CC(C=2C=NC=CC=2)=N1 HRNLUBSXIHFDHP-UHFFFAOYSA-N 0.000 description 1
241000588652 Neisseria gonorrhoeae Species 0.000 description 1
101100370014 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) tof-1 gene Proteins 0.000 description 1
208000031662 Noncommunicable disease Diseases 0.000 description 1
206010029719 Nonspecific reaction Diseases 0.000 description 1
239000001888 Peptone Substances 0.000 description 1
108010080698 Peptones Proteins 0.000 description 1
ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
206010035724 Pneumonia mycoplasmal Diseases 0.000 description 1
229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
239000004372 Polyvinyl alcohol Substances 0.000 description 1
241000589517 Pseudomonas aeruginosa Species 0.000 description 1
241000596091 Salmonella enterica subsp. enterica serovar Anatum Species 0.000 description 1
241000242680 Schistosoma mansoni Species 0.000 description 1
206010039710 Scleroderma Diseases 0.000 description 1
241000700584 Simplexvirus Species 0.000 description 1
102000008068 Tensins Human genes 0.000 description 1
108010088950 Tensins Proteins 0.000 description 1
241000223997 Toxoplasma gondii Species 0.000 description 1
201000005485 Toxoplasmosis Diseases 0.000 description 1
241000589884 Treponema pallidum Species 0.000 description 1
239000007983 Tris buffer Substances 0.000 description 1
241001442399 Trypanosoma brucei gambiense Species 0.000 description 1
241001442397 Trypanosoma brucei rhodesiense Species 0.000 description 1
241000223109 Trypanosoma cruzi Species 0.000 description 1
102000003990 Urokinase-type plasminogen activator Human genes 0.000 description 1
108090000435 Urokinase-type plasminogen activator Proteins 0.000 description 1
241000251539 Vertebrata <Metazoa> Species 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
231100000354 acute hepatitis Toxicity 0.000 description 1
230000006978 adaptation Effects 0.000 description 1
238000003450 affinity purification method Methods 0.000 description 1
230000004520 agglutination Effects 0.000 description 1
238000013019 agitation Methods 0.000 description 1
229930013930 alkaloid Natural products 0.000 description 1
230000003321 amplification Effects 0.000 description 1
238000004458 analytical method Methods 0.000 description 1
239000004599 antimicrobial Substances 0.000 description 1
238000003149 assay kit Methods 0.000 description 1
238000011888 autopsy Methods 0.000 description 1
230000001580 bacterial effect Effects 0.000 description 1
230000000035 biogenic effect Effects 0.000 description 1
239000012472 biological sample Substances 0.000 description 1
239000012888 bovine serum Substances 0.000 description 1
201000003984 candidiasis Diseases 0.000 description 1
125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
239000001768 carboxy methyl cellulose Substances 0.000 description 1
235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
239000008112 carboxymethyl-cellulose Substances 0.000 description 1
229940105329 carboxymethylcellulose Drugs 0.000 description 1
239000003054 catalyst Substances 0.000 description 1
210000003855 cell nucleus Anatomy 0.000 description 1
210000003850 cellular structure Anatomy 0.000 description 1
210000003756 cervix mucus Anatomy 0.000 description 1
230000001684 chronic effect Effects 0.000 description 1
239000007979 citrate buffer Substances 0.000 description 1
230000035602 clotting Effects 0.000 description 1
239000005515 coenzyme Substances 0.000 description 1
239000003086 colorant Substances 0.000 description 1
230000000536 complexating effect Effects 0.000 description 1
230000001268 conjugating effect Effects 0.000 description 1
230000021615 conjugation Effects 0.000 description 1
239000000356 contaminant Substances 0.000 description 1
239000013068 control sample Substances 0.000 description 1
238000001816 cooling Methods 0.000 description 1
230000009260 cross reactivity Effects 0.000 description 1
230000001351 cycling effect Effects 0.000 description 1
230000002950 deficient Effects 0.000 description 1
235000014113 dietary fatty acids Nutrition 0.000 description 1
239000012470 diluted sample Substances 0.000 description 1
230000003292 diminished effect Effects 0.000 description 1
231100000676 disease causative agent Toxicity 0.000 description 1
229910000397 disodium phosphate Inorganic materials 0.000 description 1
239000012153 distilled water Substances 0.000 description 1
239000003814 drug Substances 0.000 description 1
230000005670 electromagnetic radiation Effects 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
229940096118 ella Drugs 0.000 description 1
239000003995 emulsifying agent Substances 0.000 description 1
229940007078 entamoeba histolytica Drugs 0.000 description 1
230000007613 environmental effect Effects 0.000 description 1
239000003344 environmental pollutant Substances 0.000 description 1
239000003248 enzyme activator Substances 0.000 description 1
239000002532 enzyme inhibitor Substances 0.000 description 1
210000003743 erythrocyte Anatomy 0.000 description 1
238000001704 evaporation Methods 0.000 description 1
230000008020 evaporation Effects 0.000 description 1
230000007717 exclusion Effects 0.000 description 1
230000001747 exhibiting effect Effects 0.000 description 1
208000022195 farmer lung disease Diseases 0.000 description 1
208000006275 fascioliasis Diseases 0.000 description 1
239000000194 fatty acid Substances 0.000 description 1
229930195729 fatty acid Natural products 0.000 description 1
150000004665 fatty acids Chemical class 0.000 description 1
239000002657 fibrous material Substances 0.000 description 1
239000000706 filtrate Substances 0.000 description 1
244000144992 flock Species 0.000 description 1
101150020161 flu-2 gene Proteins 0.000 description 1
238000002523 gelfiltration Methods 0.000 description 1
239000008103 glucose Substances 0.000 description 1
125000004395 glucoside group Chemical group 0.000 description 1
239000007973 glycine-HCl buffer Substances 0.000 description 1
208000001786 gonorrhea Diseases 0.000 description 1
210000005256 gram-negative cell Anatomy 0.000 description 1
231100001261 hazardous Toxicity 0.000 description 1
230000036541 health Effects 0.000 description 1
208000006454 hepatitis Diseases 0.000 description 1
229930195733 hydrocarbon Natural products 0.000 description 1
150000002430 hydrocarbons Chemical class 0.000 description 1
239000012051 hydrophobic carrier Substances 0.000 description 1
230000005661 hydrophobic surface Effects 0.000 description 1
230000008105 immune reaction Effects 0.000 description 1
230000028993 immune response Effects 0.000 description 1
230000000984 immunochemical effect Effects 0.000 description 1
230000002163 immunogen Effects 0.000 description 1
239000012678 infectious agent Substances 0.000 description 1
230000002401 inhibitory effect Effects 0.000 description 1
238000011081 inoculation Methods 0.000 description 1
229940125396 insulin Drugs 0.000 description 1
208000028774 intestinal disease Diseases 0.000 description 1
238000010253 intravenous injection Methods 0.000 description 1
238000011835 investigation Methods 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
230000002147 killing effect Effects 0.000 description 1
239000004816 latex Substances 0.000 description 1
229920000126 latex Polymers 0.000 description 1
230000000670 limiting effect Effects 0.000 description 1
101150096059 lipC gene Proteins 0.000 description 1
244000144972 livestock Species 0.000 description 1
206010025135 lupus erythematosus Diseases 0.000 description 1
210000002751 lymph Anatomy 0.000 description 1
201000004792 malaria Diseases 0.000 description 1
239000002207 metabolite Substances 0.000 description 1
229910052751 metal Inorganic materials 0.000 description 1
239000002184 metal Substances 0.000 description 1
150000002739 metals Chemical class 0.000 description 1
229920000609 methyl cellulose Polymers 0.000 description 1
239000001923 methylcellulose Substances 0.000 description 1
239000012569 microbial contaminant Substances 0.000 description 1
244000005700 microbiome Species 0.000 description 1
239000012229 microporous material Substances 0.000 description 1
239000012982 microporous membrane Substances 0.000 description 1
238000002156 mixing Methods 0.000 description 1
230000007935 neutral effect Effects 0.000 description 1
238000006386 neutralization reaction Methods 0.000 description 1
238000011587 new zealand white rabbit Methods 0.000 description 1
230000009871 nonspecific binding Effects 0.000 description 1
238000003199 nucleic acid amplification method Methods 0.000 description 1
125000002524 organometallic group Chemical group 0.000 description 1
230000020477 pH reduction Effects 0.000 description 1
244000045947 parasite Species 0.000 description 1
239000002245 particle Substances 0.000 description 1
230000035515 penetration Effects 0.000 description 1
235000019319 peptone Nutrition 0.000 description 1
239000002831 pharmacologic agent Substances 0.000 description 1
239000012071 phase Substances 0.000 description 1
239000002985 plastic film Substances 0.000 description 1
239000004417 polycarbonate Substances 0.000 description 1
229920000515 polycarbonate Polymers 0.000 description 1
229920002451 polyvinyl alcohol Polymers 0.000 description 1
238000011176 pooling Methods 0.000 description 1
235000013594 poultry meat Nutrition 0.000 description 1
239000000843 powder Substances 0.000 description 1
239000002244 precipitate Substances 0.000 description 1
102000004196 processed proteins & peptides Human genes 0.000 description 1
108090000765 processed proteins & peptides Proteins 0.000 description 1
230000000135 prohibitive effect Effects 0.000 description 1
QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 1
125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 1
238000002731 protein assay Methods 0.000 description 1
238000012205 qualitative assay Methods 0.000 description 1
238000011002 quantification Methods 0.000 description 1
230000002285 radioactive effect Effects 0.000 description 1
239000012857 radioactive material Substances 0.000 description 1
238000003127 radioimmunoassay Methods 0.000 description 1
239000011541 reaction mixture Substances 0.000 description 1
230000009257 reactivity Effects 0.000 description 1
230000009467 reduction Effects 0.000 description 1
239000004627 regenerated cellulose Substances 0.000 description 1
238000009877 rendering Methods 0.000 description 1
230000002441 reversible effect Effects 0.000 description 1
238000011309 routine diagnosis Methods 0.000 description 1
239000012898 sample dilution Substances 0.000 description 1
201000004409 schistosomiasis Diseases 0.000 description 1
239000013049 sediment Substances 0.000 description 1
238000003375 selectivity assay Methods 0.000 description 1
239000000377 silicon dioxide Substances 0.000 description 1
235000017557 sodium bicarbonate Nutrition 0.000 description 1
229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
JQWHASGSAFIOCM-UHFFFAOYSA-M sodium periodate Chemical compound [Na+].[O-]I(=O)(=O)=O JQWHASGSAFIOCM-UHFFFAOYSA-M 0.000 description 1
239000001488 sodium phosphate Substances 0.000 description 1
229910000162 sodium phosphate Inorganic materials 0.000 description 1
235000021055 solid food Nutrition 0.000 description 1
239000002195 soluble material Substances 0.000 description 1
239000002904 solvent Substances 0.000 description 1
239000000600 sorbitol Substances 0.000 description 1
241000894007 species Species 0.000 description 1
230000002311 subsequent effect Effects 0.000 description 1
238000003786 synthesis reaction Methods 0.000 description 1
229920002994 synthetic fiber Polymers 0.000 description 1
208000006379 syphilis Diseases 0.000 description 1
230000009885 systemic effect Effects 0.000 description 1
206010052366 systemic mycosis Diseases 0.000 description 1
238000010998 test method Methods 0.000 description 1
239000012085 test solution Substances 0.000 description 1
231100000331 toxic Toxicity 0.000 description 1
230000002588 toxic effect Effects 0.000 description 1
RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
OOLLAFOLCSJHRE-ZHAKMVSLSA-N ulipristal acetate Chemical compound C1=CC(N(C)C)=CC=C1[C@@H]1C2=C3CCC(=O)C=C3CC[C@H]2[C@H](CC[C@]2(OC(C)=O)C(C)=O)[C@]2(C)C1 OOLLAFOLCSJHRE-ZHAKMVSLSA-N 0.000 description 1
241000712461 unidentified influenza virus Species 0.000 description 1
241001515965 unidentified phage Species 0.000 description 1
229960005356 urokinase Drugs 0.000 description 1
238000003828 vacuum filtration Methods 0.000 description 1
239000011782 vitamin Substances 0.000 description 1
235000013343 vitamin Nutrition 0.000 description 1
229940088594 vitamin Drugs 0.000 description 1
229930003231 vitamin Natural products 0.000 description 1

Landscapes

Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Apparatus Associated With Microorganisms And Enzymes (AREA)
Peptides Or Proteins (AREA)

CA 2019048 1990-06-14 1990-06-14 Methode de dosage immunologique Expired - Lifetime CA2019048C (fr)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
CA 2019048 CA2019048C (fr)	1990-06-14	1990-06-14	Methode de dosage immunologique

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
CA 2019048 CA2019048C (fr)	1990-06-14	1990-06-14	Methode de dosage immunologique

Publications (2)

Publication Number	Publication Date
CA2019048A1 CA2019048A1 (fr)	1991-12-14
CA2019048C true CA2019048C (fr)	2003-02-25

Family

ID=4145236

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
CA 2019048 Expired - Lifetime CA2019048C (fr)	1990-06-14	1990-06-14	Methode de dosage immunologique

Country Status (1)

Country	Link
CA (1)	CA2019048C (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102236014A (zh) *	2010-04-20	2011-11-09	艾博生物医药(杭州)有限公司	一种基于免疫反应原理的检测试剂条
RU2715561C1 (ru) *	2019-11-14	2020-03-02	Федеральное бюджетное учреждение науки "Ростовский научно-исследовательский институт микробиологии и паразитологии" (ФБУН "Ростов НИИ микробиологи и паразитологии")	Способ контроля специфичности лактоглобулина против условно-патогенных бактерий и сальмонелл по содержанию антител методом иммуноферментного анализа

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN113125708B (zh) *	2019-12-31	2023-01-20	暨南大学	一种基于核孔膜的微孔板及其制备方法与应用

1990
- 1990-06-14 CA CA 2019048 patent/CA2019048C/fr not_active Expired - Lifetime

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN102236014A (zh) *	2010-04-20	2011-11-09	艾博生物医药(杭州)有限公司	一种基于免疫反应原理的检测试剂条
RU2715561C1 (ru) *	2019-11-14	2020-03-02	Федеральное бюджетное учреждение науки "Ростовский научно-исследовательский институт микробиологии и паразитологии" (ФБУН "Ростов НИИ микробиологи и паразитологии")	Способ контроля специфичности лактоглобулина против условно-патогенных бактерий и сальмонелл по содержанию антител методом иммуноферментного анализа

Also Published As

Publication number	Publication date
CA2019048A1 (fr)	1991-12-14

Legal Events

Date	Code	Title	Description
1995-10-25	EEER	Examination request
2010-06-14	MKEX	Expiry

Publication	Publication Date	Title
US5169757A (en)	1992-12-08	Antibodies or antigens bound to a macroporous hydrophobic synthetic polymer cloth for immunological techniques
US4407943A (en)	1983-10-04	Immobilized antibody or antigen for immunoassay
US4960715A (en)	1990-10-02	Diagnostic test methods
US4332783A (en)	1982-06-01	Process for immunologic determination tests
AU748387B2 (en)	2002-06-06	Neutralization of polycations in a chromatographic device for whole blood use
US4508829A (en)	1985-04-02	Method and kit for pregnancy detection
EP0209273B1 (fr)	1991-04-24	Méthode pour la détection, pour la séparation et pour la purification de la toxine A de clostridium difficile et de ses récepteurs
US5200312A (en)	1993-04-06	Membrane based dot immunoassay and method of use
US4474878A (en)	1984-10-02	Sandwich EIA for antigen associated with hepatitis
WO1984002193A1 (fr)	1984-06-07	Analyse immunologique a support chromogene
US5155022A (en)	1992-10-13	Assay for lyme disease
US5122452A (en)	1992-06-16	Enzyme immunoassay with a macroporous hydrophobic synthetic polymer cloth containing an immobilized antibody or antigen
EP0643307A1 (fr)	1995-03-15	Procédé d'immunoessai visuel pour la détection de ligands, utilisant des supports en plastique opaques
JP2732124B2 (ja)	1998-03-25	固相免疫検定用品及び該品を利用した検定法
US4812414A (en)	1989-03-14	Immunoreactive reagent particles having tracer, receptor molecules and protein of pI less than 6
US4828978A (en)	1989-05-09	Agglutination reagent and method of preparing same
WO1997023781A1 (fr)	1997-07-03	Procede et dispositif d'analyse de matieres fecales
CA2019048C (fr)	2003-02-25	Methode de dosage immunologique
US4814269A (en)	1989-03-21	Diagnostic testing for antibodies against microorganisms
CA1106281A (fr)	1981-08-04	Detection d'un antigene associe a l'hepatite au moyen de la methode dite "sandwich"
JPS60500548A (ja)	1985-04-18	発色性支持体免疫測定法
EP0152254A2 (fr)	1985-08-21	Immunoessai à base d'un support chromogénique utilisant des composants complémentaires marqués
EP0451687A2 (fr)	1991-10-16	Essai immunologique du type sandwich partiel pour détermination de chlamydia
KR970007080B1 (ko)	1997-05-02	자체-완비된 다중-면역분석 진단시스템
CA1291949C (fr)	1991-11-12	Dosage immuno-enzymologique sur tissu

CA2019048C - Methode de dosage immunologique - Google Patents

Info

Links

Landscapes

Priority Applications (1)

Applications Claiming Priority (1)

Publications (2)

Family

ID=4145236

Family Applications (1)

Country Status (1)

Cited By (2)

Families Citing this family (1)

Cited By (2)

Also Published As

Similar Documents

Legal Events